Commentary: Europe needs a central, transparent, and evidence based regulation process for devices

被引:30
作者
Eikermann, Michaela [1 ]
Gluud, Christian [2 ]
Perleth, Matthias [3 ]
Wild, Claudia [4 ]
Sauerland, Stefan [5 ]
Gutierrez-Ibarluzea, Inaki [6 ]
Antoine, Sunya-Lee [1 ]
Demotes-Mainard, Jacques [7 ]
Neugebauer, Edmund A. M. [1 ]
机构
[1] Univ Witten Herdecke, Sch Med, Fac Hlth, Inst Res Operat Med, D-51109 Cologne, Germany
[2] Copenhagen Univ Hosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark
[3] German Soc Technol Assessment Hlth Care, Berlin, Germany
[4] Ludwig Boltzmann Inst Hlth Technol Assessment, Vienna, Austria
[5] Inst Qual & Efficiency Healthcare IQWiG, Cologne, Germany
[6] Osteba, Basque Off Hlth Technol Assessment, Vitoria, Spain
[7] INSERM, Inst Themat Sante Publ, Paris, France
来源
BMJ-BRITISH MEDICAL JOURNAL | 2013年 / 346卷
基金
英国医学研究理事会;
关键词
D O I
10.1136/bmj.f2771
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:2
相关论文
共 3 条
[1]  
Campbell B, 2013, BRIT MED J, V346, pf2374
[2]  
Eikermann M, 2013, EVIDENCE LIVE
[3]   Trials are needed before new devices are used in routine practice in Europe [J].
Storz-Pfennig, Philipp ;
Schmedders, Mechtild ;
Dettloff, Matthias .
BMJ-BRITISH MEDICAL JOURNAL, 2013, 346